Scientific Industries (SCND)
(Delayed Data from OTC)
$1.75 USD
0.00 (0.00%)
Updated Apr 25, 2024 09:51 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Scientific Industries Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 11 | 0 | 11 | 10 | 9 |
Cost Of Goods | 6 | 0 | 6 | 5 | 5 |
Gross Profit | 5 | 0 | 6 | 5 | 4 |
Selling & Adminstrative & Depr. & Amort Expenses | 14 | 0 | 13 | 10 | 5 |
Income After Depreciation & Amortization | -9 | 0 | -7 | -5 | -1 |
Non-Operating Income | 0 | 0 | 0 | 1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -9 | 0 | -7 | -4 | -1 |
Income Taxes | 0 | 0 | -1 | -1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -9 | 0 | -6 | -3 | -1 |
Extras & Discontinued Operations | 0 | 0 | 0 | -1 | 0 |
Net Income (GAAP) | -9 | 0 | -6 | -4 | -1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | 0 | -7 | -4 | -1 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -9 | 0 | -7 | -5 | -1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.15 | 6.64 | 3.19 | 1.52 | 1.51 |
Diluted EPS Before Non-Recurring Items | -1.27 | -0.85 | -0.97 | -0.46 | 0.43 |
Diluted Net EPS (GAAP) | -1.27 | -0.85 | -0.85 | -1.15 | -0.46 |
Fiscal Year end for Scientific Industries Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2.74 | 2.59 | 2.98 | 2.81 |
Cost Of Goods | NA | 1.51 | 1.40 | 1.63 | 1.47 |
Gross Profit | NA | 1.23 | 1.18 | 1.35 | 1.34 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.57 | 3.41 | 3.57 | 3.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.34 | -2.23 | -2.22 | -2.46 |
Non-Operating Income | NA | 0.01 | 0.02 | 0.04 | 0.10 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -2.33 | -2.20 | -2.19 | -2.37 |
Income Taxes | NA | -0.11 | 0.00 | 0.11 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.22 | -2.20 | -2.29 | -2.37 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.22 | -2.20 | -2.29 | -2.37 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 7.00 | 7.00 | 7.00 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.31 | -0.33 | -0.34 |
Diluted Net EPS (GAAP) | NA | -0.29 | -0.31 | -0.33 | -0.34 |